Medicover AB (publ) (FRA:5M0B)
Germany · Delayed Price · Currency is EUR 19.34
-0.16 (-0.82%)
At close: Jan 30, 2026
Medicover AB Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 67.3 | 16.7 | 17.6 | 11.8 | 101.8 | 25.8 |
Depreciation & Amortization | 178.8 | 183.1 | 170.2 | 149.7 | 104.2 | 84.6 |
Other Amortization | 15.1 | 15.1 | 12.4 | 9.5 | 6.8 | 6.4 |
Asset Writedown & Restructuring Costs | 16.4 | 16.4 | -0.2 | 2.7 | - | 5.2 |
Loss (Gain) From Sale of Investments | - | - | - | 1.3 | -0.4 | -1.3 |
Stock-Based Compensation | 14.3 | 12.2 | 9.4 | 9.6 | 6.4 | 4.7 |
Other Operating Activities | 40.5 | 36.4 | 10 | 25.2 | 38.8 | 31.3 |
Change in Accounts Receivable | -60.4 | -53.3 | -29.1 | -26.7 | -49.5 | -29.3 |
Change in Inventory | 6.2 | -8.2 | -5.1 | 12.7 | -17.1 | -22 |
Change in Accounts Payable | 29.6 | 43.5 | 19.8 | -25.6 | 25.7 | 49.7 |
Operating Cash Flow | 307.8 | 261.9 | 205 | 170.2 | 216.7 | 155.1 |
Operating Cash Flow Growth | 28.14% | 27.76% | 20.45% | -21.46% | 39.72% | 77.66% |
Capital Expenditures | -141.9 | -122.3 | -110.5 | -140.6 | -102.2 | -72.5 |
Sale of Property, Plant & Equipment | 1.1 | 2.2 | 1.4 | 3 | 2.1 | 0.9 |
Cash Acquisitions | -173.8 | -18.1 | -19.6 | -229.1 | -87.5 | -12.2 |
Divestitures | 0.1 | 0.1 | 14 | - | - | - |
Investment in Securities | 1.3 | -2.3 | -1.6 | 180.1 | -144.2 | -43.6 |
Other Investing Activities | 6.8 | 5.6 | 4 | 1.8 | 1 | 1.2 |
Investing Cash Flow | -306.3 | -134.7 | -119.8 | -184.8 | -333.6 | -126.3 |
Long-Term Debt Issued | - | 884.8 | 461.9 | 524.1 | 293.7 | 181.4 |
Long-Term Debt Repaid | - | -829.2 | -462.8 | -485.3 | -93.2 | -319.2 |
Net Debt Issued (Repaid) | 168.3 | 55.6 | -0.9 | 38.8 | 200.5 | -137.8 |
Issuance of Common Stock | - | - | 0.3 | - | 0.3 | 143 |
Repurchase of Common Stock | - | - | -0.3 | - | -0.3 | - |
Common Dividends Paid | -22.5 | -18 | -17.9 | -17.8 | -10.4 | - |
Other Financing Activities | -127.6 | -145.6 | -54.9 | -45.3 | -26 | -18.4 |
Financing Cash Flow | 18.2 | -108 | -73.7 | -24.3 | 164.1 | -13.2 |
Foreign Exchange Rate Adjustments | -2 | -0.2 | -1.1 | -2.6 | -12 | -3.7 |
Net Cash Flow | 17.7 | 19 | 10.4 | -41.5 | 35.2 | 11.9 |
Free Cash Flow | 165.9 | 139.6 | 94.5 | 29.6 | 114.5 | 82.6 |
Free Cash Flow Growth | 35.98% | 47.73% | 219.26% | -74.15% | 38.62% | 242.74% |
Free Cash Flow Margin | 7.14% | 6.67% | 5.41% | 1.96% | 8.31% | 8.28% |
Free Cash Flow Per Share | 1.10 | 0.93 | 0.63 | 0.20 | 0.77 | 0.58 |
Cash Interest Paid | 62.1 | 59.4 | 46.5 | 32.4 | 19.7 | 15.8 |
Cash Income Tax Paid | 39.7 | 19.2 | 28.8 | 19.1 | 18.3 | 11 |
Levered Free Cash Flow | 116.1 | 89 | 70.86 | 56.68 | 90.66 | 74.59 |
Unlevered Free Cash Flow | 155.54 | 125.75 | 102.99 | 78.24 | 103.23 | 85.9 |
Change in Working Capital | -24.6 | -18 | -14.4 | -39.6 | -40.9 | -1.6 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.